SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清爽的非笑
Lv3
290 积分
2024-04-05 加入
最近求助
最近应助
互助留言
[Protocols for treatment of multiple organ dysfunction syndrome/severe sepsis combined of traditional Chinese medicine and Western medicine]
3天前
求助中
Cell Surface Markers and their Targeted Drugs in Breast Cancer
26天前
已完结
Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study
1个月前
已完结
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
1个月前
已完结
128TiP A phase II study of cadonilimab + FOLFOXIRI and bevacizumab as initial therapy for unresectable proficient mismatch repair/microsatellite stable (pMMR/MSS) metastatic colorectal cancer (mCRC)
1个月前
已关闭
A phase II clinical study to evaluate the efficacy and safety of cadonilimab in combination with radiotherapy versus radiotherapy alone in the adjuvant treatment of locally advanced endometrial cancer
1个月前
已关闭
494TiP Efficacy and safety of cadonilimab and COX-2 inhibitor combined with oxaliplatin and capecitabine (XELOX) in perioperative treatment for locally advanced resectable gastric adenocarcinoma: A prospective, single-center, randomized, phase II trial
1个月前
已完结
A randomized, double-blind, placebo-controlled phase III study to evaluate AK104 plus platinum-containing chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer
1个月前
已关闭
Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis
1个月前
已完结
The cancer-immunity cycle: Indication, genotype, and immunotype
1个月前
已完结
没有进行任何应助
感谢
1个月前
速度真快,帮大忙了
1个月前
速度真快
2个月前
感谢
2个月前
感谢
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论